IFI-M · CAK Tri-Axis Balanced Series

Specimen SS-F-M3-02115 // MULTI-AXIS · IFI-M

CAK Tri-Axis Balanced Series III-NP

Mentha × piperita

Peppermint

Tier IIICAK Tri-Axis Balanced Series

Target Trait

1.75×

fold-change

Cooling+Astringency+Kokumi balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-02115

Genomic Edits

9

GC Content

48.7%

Construct Length

5,316 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

TRPM8 + Polyphenol-astringency axis + CaSR

IFI Score

175

Pathway Edits

  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent CAK pathway operation
  • Cross-pathway regulatory circuit for balanced CAK triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, Polyphenol-astringency axis, and CaSR pathways simultaneously engineeredBalanced tri-axis expression strategy (CAK) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III CAK triple-axis construct for advanced multi-modal sensory architecture combining cooling, astringency, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$1749 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities